Home
Find a Provider
About
Our Story
Leadership
Clinical Research
Scientific Evidence
Research Programs
Blog
News
Join Us
Contact
Press Releases
For press inquiries, please contact Amy Cook
email:
amy@magnusmed.com
phone:
925.222.5094
Press
Releases
Media
Kit
News
Coverage
Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 Hospital Outpatient Rule
November 12, 2024
Magnus Medical Highlights New Clinical Data on Groundbreaking SAINT Therapy at 2024 NYC Neuromodulation Conference
August 1, 2024
Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
April 30, 2024
Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation
October 23, 2023
Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major Depression
July 20, 2023
Magnus Medical Shares New Study Results That Find Treatment With SAINT for Severe Depression Changes Abnormal Brain Signals
May 15, 2023
Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression
September 6, 2022
Magnus Adds Three Key Hires to Executive Team
March 10, 2022
Magnus Medical Launches with Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing
October 29, 2021
